Time on boards
- Boards served
- 4
- Current seats
- 4
- Board service
- 11 years
- Director since
- 2023
11 years of board service in total across 4 boards, counting each seat separately. Longest: MiNK Therapeutics Inc., 3 years.
MiNK Therapeutics Inc.
Director
INVO Fertility Inc.
Director
Azitra Inc
Director
Indivior Pharmaceuticals Inc.
Director
Shareholder support
Support is votes for as a share of votes for and against (or withheld). Below 80% is a clear protest.
-
INVO Fertility Inc. July 23, 202692.1%
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
| Date | Company | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Sep 1, 2026 | MiNK Therapeutics Inc. | Grant or award | +1,622 | $10.95 | $17,761 |
| Jun 4, 2026 | MiNK Therapeutics Inc. | Open-market sale | −500 | $12.68 | $6,340 |
| Jun 4, 2026 | MiNK Therapeutics Inc. | Open-market sale | −1,000 | $12.80 | $12,800 |
| Jun 1, 2026 | MiNK Therapeutics Inc. | Grant or award | +1,434 | $12.38 | $17,753 |
| May 13, 2026 | Indivior Pharmaceuticals Inc. | Grant or award | +6,518 | — | — |
| Mar 13, 2026 | Indivior Pharmaceuticals Inc. | Open-market purchase | +8 | $31.09 | $249 |
| Mar 10, 2026 | MiNK Therapeutics Inc. | Open-market sale | −300 | $15.28 | $4,584 |
| Mar 10, 2026 | MiNK Therapeutics Inc. | Open-market sale | −500 | $15.57 | $7,785 |
| Mar 10, 2026 | MiNK Therapeutics Inc. | Open-market sale | −500 | $15.30 | $7,650 |
| Mar 9, 2026 | MiNK Therapeutics Inc. | Open-market sale | −200 | $10.17 | $2,034 |
| Mar 9, 2026 | Indivior Pharmaceuticals Inc. | Open-market purchase | +31 | $32.56 | $1,009 |
| Mar 2, 2026 | MiNK Therapeutics Inc. | Grant or award | +1,629 | $10.90 | $17,756 |
| Mar 2, 2026 | MiNK Therapeutics Inc. | Open-market sale | −100 | $10.83 | $1,083 |
| Feb 27, 2026 | MiNK Therapeutics Inc. | Open-market sale | −400 | $10.86 | $4,344 |
| Jan 26, 2026 | Indivior Pharmaceuticals Inc. | Grant or award | +3,722 | — | — |
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.